RMC-035

· Guard Therapeutics AB

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RMC-035, covering 2023-12-04 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery [Phase 2]